chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediate headache which  started immediately after the vaccine and continues. Muscle ache and fatigue.
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Dizziness / Lightheadness-Medium, Additional Details: Approximately 5 minutes after getting Moderna Covid Vaccine, pt complained of chest pain, throat tightening and shortness of breath. I Administered Generic epinepherine auto injector to his right thigh, and within minute or two, his breathing normalized but pt still had throat tightness. EMS arrived at that point and examined the pt and transported him to local hospital.
Pt. was seen on 6/9/09 for pap smear - during course of visit she advised provider that she refused any further GARDASIL. Stated that apx 3 hours after 1st GARDASIL, she felt disoriented - family members claim she was "in and out of reality" - dizzy, disoriented lasted for 24 hours.
About two days after I became very sore in my throat but it began to go away around the evening of day 3.  Now today on the 5th of November I woke up from an excruciating headache to the point I thought maybe I was having a mini stroke at first.  Since then my glands in my neck have swollen up, there is pressure between the space between the nose and throat in the back, my breathing is heavy, fevers continue, sore throat, post nasal drip, feel warm in my mouth and at injection site still.  Noticed an uncharacteristic change appetite the day after injection with a consistent metallic taste that hasn't gone away since.  Swelling up of feet more than normal and same with legs.  Still going through so outcome not yet known at this time.
Pt. Reported to me one week after, that he had severe uncontrollable body jerks which subsided after a few hours, also had an 8 inch bruise at injection site (R) Deltoid
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. Medical history and drug reactions or allergies were not specified. On unknown dates in 2014, reported as from 10-JUN-2014 to 18-JUL-2014, an unspecified number of patients were vaccinated with doses of RECOMBIVAX HB (dose number, dose, route and lot number were not reported), which were improperly stored. No adverse events were reported. Concomitant medications were not specified. Follow up information was received from the medical assistant on 06-AUG-2014. The M.A. stated the temperature excursions occurred on two different dates: 10-JUN-2014, 51 degrees Fahrenheit for 5 minutes and on 18-JUL-2014, 48 degrees Fahrenheit for 24-minutes. The M.A. also stated she did not have patients identifiers, lot numbers, expiration dates, or dates of administration available at the time. Follow up information has been received on 06-AUG-2014 from medical assistant and refers to 4 week old patient who on 10-JUN-2014 was vaccinated with improperly stored dose of RECOMBIVAX HB Lot# J012567, expiration date 30-JAN-2016 (dose and route of administration not reported). This is one of several reports received from the same reporter. Additional information is not expected.
rash began about 1 hour after shot given- whelp type rash to trunk/extremities with swelling of eyes/face; benadryl given; c/o abdominal pain & low grade fever through night. Seen at urgent care clinic following a.m.-given Zyrtec and Pepcid with improvement in symptoms over next few hours-active/alert/NAD
MA believes that she checked the expiration date prior to Administration. However, on 7/14/2023, there were 2 doses extra left over in the same lot number, when there should have been 0 per internal inventory, Since it is not possible to pinpoint which doses caused the overage, it appears 1 or more doses given between 6/9/2023 and 7/7/2023 may have been expired- 12 hours after opening and reused, therefore all doses given during that period are considered to potentially be expired.
Pregnant patient received the vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the vaccine) in a 25-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for Allergy, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.    On 11-Feb-2021 at 6:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 08-Oct-2020 and the estimated date of delivery was 20-Jul-2021. On 11-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  eighteenth week of the pregnancy.  On 11-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Nov-2020, Pregnancy test: positive (Positive) Positive. On 08-Dec-2020, Ultrasound scan: normal (normal) Ultrasound was also done on 03-FEB-2021, result was normal.. On 13-Jan-2021, Blood test: normal (normal) Blood test was also done on 03-FEB-2021, result was normal.. On 03-Feb-2021, Blood test: normal (normal) normal. On 03-Feb-2021, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include pre-natal vitamins.Treatment information was not provided.  Estimated date of conception reported was 15-Oct-2020. Patient was diagnosed with COVID-19 during pregnancy.; Sender's Comments: This case concerns a 25-Year-old female, Para1 gravida 2, who received mRNA-1273 while pregnant (vaccine exposure during pregnancy).  Positive pregnancy test was 10-NOV-2020, last menstrual period was 08-OCT-2020, a, estimated date of conception was 15-Oct-2020 and estimated due date is 20-JUN-2021. the event of vaccine exposure during pregnancy is assessed as not applicable
11 hours after shot (Sat 3/27/21 2:00am): Chills, high temp & hallucinations, then hot, neck, back, arms & legs muscles tightened, freezing for a few hours. 8:00a: wiped out. 1:00pm (Sat): chills, hot, body aches, upset stomach, slept on/off until 4 or 5pm when I started shivering, vomiting, some hallucinating. Armpit glands felt twisted and pulled. I felt worse & asked my wife to call 911. Paramedics came, took vitals, blood, offered to take me to hospital (didn?t go). They stayed an hour until I felt stable.   Sun 3/28/21am, exhausted, slightly better but my mind was spacey, body achy & armpits hurt. 12:00pm: noticed short term memory loss, ate a few crackers, drank water, napped on/ off, went to bed around 900pm.    Mon, 3/29/21, still achy and mentally fuzzy. Side effects diminished over a few days.
Vaccines received 8/23/16 - seen in ED 8/24 for "lt upper thigh erythema, swelling, warmth and redness"-dx "post vaccine rash due to DTAP." U/S done - negative. Treated empirically with antibiotic. Follow up on 8/26/16 - recovering.
New formulation and proceeded to mix it with the vial of the old formulation; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate reconstitution technique in a patient who received Rota (Rotarix lyophilized formulation) for prophylaxis.   On an unknown date, the patient received Rotarix lyophilized formulation. On an unknown date, an unknown time after receiving Rotarix lyophilized formulation, the patient experienced inappropriate reconstitution technique (Verbatim: New formulation and proceeded to mix it with the vial of the old formulation). The outcome of the inappropriate reconstitution technique was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 25-MAY-2023 The reporter reported that the new formulation was proceeded and mixed it with the vial of the old formulation. She wanted information on, if a patient was essentially double dosed.  Additionally, if this was patients first dose what was the recommendation for a second dose. Request was made through system. The new formulation was proceeded and mixed it with the vial of the old formulation which led to inappropriate reconstitution technique.
PATIENT RECEIVED PFIZER VACCINE ON 08/16/2021 AND ON 09/07/2021. PATIENT CAME IN ON 01/14/2022 AND WAS ADMINISTERED A BOOSTER DOSE BEFORE THE 5 MONTH PERIOD
This spontaneous case was reported by a patient and describes the occurrence of (Dehydrated), (Tense (Shoulder and arm pain), (Shoulder and arm pain) and (Felt achy) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for Prophylactic vaccination. Co-suspect product included non-company product DUPILUMAB solution for injection for Atopic dermatitis. The patient's past medical history included Injection site swelling from 27-Jul-2021 to 29-Jul-2021, Injection site burning from 27-Jul-2021 to 29-Jul-2021, Injection site tingling from 27-Jul-2021 to 29-Jul-2021 and Injection site warmth from 27-Jul-2021 to 29-Jul-2021. On 13-Jul-2021, the patient started (Subcutaneous) 600 milligrams. On 27-Jul-2021, (Subcutaneous) dosage was changed to 300 milligrams. On 01-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, the patient experienced (Dehydrated), (Dehydrated), (Tense (Shoulder and arm pain), (Shoulder and arm pain) and (Felt achy) had resolved.   Concomitant product use was not provided by the reporter. On 13-Jul-2021, the patient started taking Dupilumab injection initial loading dose with Dupixent single dose pre-filled pen. On 27-Jul-2021, the patient gave herself Dupilumab maintenance dose in the upper thigh. When the patient did the injection, the injection site felt swollen, there was like a burning and tingling sensation there, and it felt warm for about 2 days after the injection. There was no reported treatment and the event had been resolved. Dupixent was continued. On 30-Nov-2021, the patient had Dupixent injection. On 01-Dec-2021, the patient received Moderna booster dose and felt achy, dehydrated, tense, had shoulder and arm pain. They lasted for approximately 36 hours and resolved on 02-Dec-2021. On 28-Dec-2021, the patient took Dupixent, when heard the second click, counted to ten, the liquid came pouring out down her right leg and the site was swollen. The length of time that the product was allowed to come to room temperature was 45 minutes to an hour. The leaking was during administration with Dupixent. No treatment information was provided. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked in.
I tested positive for Covid-19 on August 22, 20022 I experienced mild symptoms and did not experience any symptoms.
Patient received a flu shot on 9/28/12. She called the pharmacy 9/29 around 10 am. She said her throat started swelling 9/28 & her eyes were running green mucous, very tired. She took BENADRYL and is feeling better.
Employee came up at 14:00 stated she had a headache. Also said her joints ached. She then also said her throat was sore and that it had been for last 15 minutes and she was trying to wait it out. Asked if she should just go home and take benadryl. I advised that I could not make that determination and would prefer she get checked out. Walked her to the emergency room.  She was in no distress and was checked into the ED.
Shoulder, arm, elbow, back leg, foot pain.   Arm, hand weakness, numbness.    Prednisone drug alleviated pain for 5 days, but pain returned after prescription expired.
rash/hives on my neck and arms; rash/hives on my neck and arms; This is a spontaneous report from a contactable consumer(patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on 30Mar2021 as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced rash/hives on his neck and arms on 31Mar2021. The outcome was unknown for the reported events.  No follow-up attempts are possible. Information on batch/lot number cannot be obtained. No further information is expected.
Severe loss of cognitive function: short memory loss, inability to form words, non-epileptic seizure ( loss of motor control in legs), severe lethargy, severe loss of word recall. All symptoms lasted for 14-17 days. At present, 85% return to normal function but not 100% compared to pre-vaccine function.
pt recvd vax; pt devel fever, aches, stuffy nose & a cough & was seen by MD;
seizures; heart pauses; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 23 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21May2021 13:15 (Lot number: EW0168) at the age of 23 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0175, Location of injection: Arm Left, Vaccine Administration Time: 02:30 PM), administration date: 30Apr2021, when the patient was 23 years old, for COVID-19 Immunization. The following information was reported: SEIZURE (hospitalization, medically significant, life threatening) with onset 08Jan2022 12:00, outcome "not recovered", described as "seizures"; CARDIAC DISORDER (hospitalization, life threatening) with onset 08Jan2022 12:00, outcome "not recovered", described as "heart pauses". The patient was hospitalized for seizure, cardiac disorder (hospitalization duration: 14 day(s)). The events "seizures" and "heart pauses" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (08Jan2022) negative. Therapeutic measures were taken as a result of seizure, cardiac disorder. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Clinical course: My son got his 2nd vaccine and immediately complained of side effects. He started visiting numerous doctors and had 96 Different events related to his side effects. On 08Jan2022 he started having seizures and heart pauses and he is currently at (hospital name withheld) ICU about to die from his complications. He was a healthy 23 year old male with no underlying conditions. Your vaccine is killing my son and he does not have long to live. The doctors at hospital can't Find the cause and the cure. The cause is your vaccine it will kill him, we need a miracle. AE resulted in : [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event)] Treatment received for the adverse event included Plasma transfusions currently. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19.
Patient received 2 doses of the Pfizer COVID19 vaccine, dose 1 on 1/26/21 and dose 2 on 2/16/21.  Patient traveled domestically by plane to another state and then by cruise ship and by plane again to return to home state (8/7/21 - 8/12/21) .  Patient then became symptomatic on 8/15/21 with shortness of breath, cough, diarrhea, nausea, anorexia, dizziness, chills, fever, headache, congestion, fatigue, and low O2 levels ~85% - 89%. Patient still symptomatic as of 8/24/21 and instructed to follow up with a provider ASAP for low oxygen levels below 90%.
Father noticed redness on upper (L) arm 5-1-13 when child got up. On 5-3-13 upper (L) arm red, warm to touch, and swollen on outer arm. Redness & swelling around arm almost like band but does not go to back of arm approx 4-5" wide. Father states sx increased over days. Sent to PCP for eval.
Patient got extremely tired and can't seem to be up for more than 3 hours at a time. Also had severe leg pain (even with medication, pain scale at 8 (usually 2 on pain scale with pain med) 5 days later when patient reported these symptoms has occurred, patient said she was doing better but still very tired and leg pain has gone down.
redness, swelling, pain within 24 hours of injection. Swelling & pain subsided with in 2 days. Raised red mark (approx. 2 inches around was present for almost 2 weeks. Raised mark has subsided, but still faint redness.
Myoclonic seizures; Vaccination related malaise; This spontaneous case was reported by a consumer and describes the occurrence of MYOCLONIC EPILEPSY (Myoclonic seizures) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYOCLONIC EPILEPSY (Myoclonic seizures) (seriousness criterion medically significant) and VACCINATION COMPLICATION (Vaccination related malaise). At the time of the report, MYOCLONIC EPILEPSY (Myoclonic seizures) and VACCINATION COMPLICATION (Vaccination related malaise) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was provided. Treatment information was not available.  Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded; Sender's Comments: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded
Initial report received from a healthcare professional on 01 May 2013. This is an invalid case as individual patient identifiers are missing. the patients (four patients whose gender, date of birth and age were not reported), had received dose 2 of MENACTRA vaccine (lot number, route and site of adminsitration) on unspecified date. The patients had received previous dose of MENACTRA vaccine before two months on unspecified date. The patients were HIV positive. Concomitant medication and illness at the time of vaccination were not reported. It was reported that, the patient had received two doses of vaccine in two months apart instead of three months apart leading to inappropriate schedule of drug administration. On unspecified date, "meningitis ab" titer was done and one month after, insufficient range was observed for three of the patients. Corrective treatments and laboratory data were not reported. At the time of this report, the outcome was not reported. List of documents held by sender: none.
This case was reported by a healthcare professional and described the occurrence of injection site inflammation in a 70 year old female subject who was vaccinated with Fluarix for prophylaxis. The subject's medical history included femoral venous bypass graft, lichen nitidus, ovarian cancer and rheumatoid arthritis. The subject had received influenza virus vaccine in previous years with no subsequent adverse events. Concurrent medications include Extra strength Tylenol, Tiazac, Diavan, Synthroid, Nexium, Plavix. On 07 November 2006 the subject received a dose of Fluarix in the left deltoid. On 07 November 2006, less than one day after vaccination with Fluarix, the subject experienced injection site inflammation and a lump injection site. On an unspecified date after 07 November 2006 and on or before 28 November 2006, the subject experienced injection site rash and injections site papule. The subject did not have pain or itching at the injection site. The subject was seen at a physician's office. At the time of initial reporting, 28 November 2006, the events were ongoing.  Follow-up was received from the healthcare professional on 11 December 2006.  The events had improved on 07 December 2006.  The healthcare professional considered the events to be related to vaccination with FLUARIX.
Rash, Cough, Fever - Information has been received from a registered nurse concerning a 1 year old female who on 01 Feb 2000 was vaccinated with one dose of varicella virus vaccine live.  On 10 Feb 2000 the patient experienced a rash of red bumps which started on the face, slight fever, and cough.  She presented to a physician.
7JAN93 recvd MMR/Td 2-3 wks later-pain in joints; still have pain in knees;
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. No pertinent medical history or drug reactions/allergies were provided. The registered nurse reported that improperly stored GARDASIL INJ was administered to unspecified number of patient (dose, route and lot number not provided), (dates unspecified). No adverse effects were reported. This case is linked to case MARRS # 1409USA010731 (same reporter link). Additional information is not expected because there was no consent to follow up.
Swelling, Redness on the site of injection. Shortness of Breath next day. Pain and Fever.
Almost a week after I received the vaccine, I noticed a rash on one side of my upper back (same side as the arm in which  the vaccine was given). I noticed it because it itches very slightly. It didn't hurt, but didn't go away, so 5 days later (5/10/18) I went to my dermatologist and was diagnosed with a mild case of shingles.
headache; tiredness; injection site pain; muscle pain; fever of 99.9; mild tachycardia; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 33-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8734, Expiry date: unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 07Apr2021 at 13:30 as dose 2, single for covid-19 immunization. Medical history included asthma, persistent depressive disorder from an unknown date and unknown if ongoing and no known allergies. If Covid prior vaccination, if Covid tested post vaccination and if other vaccine in four week was reported as no. Concomitant medications included bupropion (BUPROPION), ibuprofen (ADVIL 12 HOUR), azithromycin (AZO), turnera diffusa leaf (DAMIANA LEAVES) and probiotics taken for an unspecified indication, start and stop date were not reported (for all concomitant medications). On 08Apr2021, the patient experienced headache, tiredness, injection site pain, muscle pain, fever of 99.9, but also have mild tachycardia (heart rate was between 90-105 just laying in bed or sitting in a chair) from app. This started day after injection, not the day of. The patient underwent lab tests and procedures which included body temperature: 99.9 on 08Apr2021 and heart rate: between 90-105 on 08Apr2021 laying in bed or sitting in a chair. The patient did not received any treatments for adverse events. The clinical outcome of events was reported as not recovered.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
I started experiencing excessive muscle fatigue and pain in extremities, it persisted for week. After 2 weeks I contacted doctor via email. Reduced dose of Atorvastatin twice and that helped.